DE69518406T2 - Monoklonale antikörper gegen den tie-rezeptor und deren verwendung - Google Patents
Monoklonale antikörper gegen den tie-rezeptor und deren verwendungInfo
- Publication number
- DE69518406T2 DE69518406T2 DE69518406T DE69518406T DE69518406T2 DE 69518406 T2 DE69518406 T2 DE 69518406T2 DE 69518406 T DE69518406 T DE 69518406T DE 69518406 T DE69518406 T DE 69518406T DE 69518406 T2 DE69518406 T2 DE 69518406T2
- Authority
- DE
- Germany
- Prior art keywords
- monoclonal antibodies
- antibodies against
- tie receptor
- useful
- angiogenesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/220,240 US5955291A (en) | 1992-01-09 | 1994-03-29 | Antibodies recognizing tie receptor tyrosine kinase and uses thereof |
PCT/FI1995/000170 WO1995026364A1 (en) | 1994-03-29 | 1995-03-29 | Monoclonal antibodies recognizing tie-receptor and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69518406D1 DE69518406D1 (de) | 2000-09-21 |
DE69518406T2 true DE69518406T2 (de) | 2001-03-15 |
Family
ID=22822698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69518406T Expired - Lifetime DE69518406T2 (de) | 1994-03-29 | 1995-03-29 | Monoklonale antikörper gegen den tie-rezeptor und deren verwendung |
Country Status (13)
Country | Link |
---|---|
US (1) | US5955291A (de) |
EP (1) | EP0753015B1 (de) |
JP (1) | JP3683270B2 (de) |
AT (1) | ATE195533T1 (de) |
AU (1) | AU697185B2 (de) |
CA (1) | CA2185043C (de) |
DE (1) | DE69518406T2 (de) |
DK (1) | DK0753015T3 (de) |
ES (1) | ES2151595T3 (de) |
MX (1) | MX9604391A (de) |
NO (1) | NO319586B1 (de) |
NZ (1) | NZ283366A (de) |
WO (1) | WO1995026364A1 (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5955291A (en) * | 1992-01-09 | 1999-09-21 | Alitalo; Kari | Antibodies recognizing tie receptor tyrosine kinase and uses thereof |
US6818220B1 (en) | 1994-11-14 | 2004-11-16 | Licentia Ltd. | Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof |
ATE273384T1 (de) | 1995-04-06 | 2004-08-15 | Regeneron Pharma | Tie-2 liganden, herstellungsverfahren und verwendung |
US6361946B1 (en) | 1997-02-05 | 2002-03-26 | Licentia Ltd | Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
US7727761B2 (en) | 1995-08-01 | 2010-06-01 | Vegenics Limited | Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
US7063965B2 (en) | 1996-04-05 | 2006-06-20 | Regeneron Pharmaceuticals, Inc. | Nucleic acid encoding TIE-2 ligand |
US5851797A (en) * | 1996-06-19 | 1998-12-22 | Regeneron Pharmaceuticals, Inc. | Tie ligand-3, methods of making and uses thereof |
US7125714B2 (en) | 1997-02-05 | 2006-10-24 | Licentia Ltd. | Progenitor cell materials and methods |
US6350450B1 (en) | 1997-09-19 | 2002-02-26 | Genentech, Inc. | TIE ligand homologue antibody |
US5972338A (en) | 1997-09-19 | 1999-10-26 | Genentech, Inc. | Tie ligands homologues |
US6057435A (en) | 1997-09-19 | 2000-05-02 | Genentech, Inc. | Tie ligand homologues |
US6348350B1 (en) | 1997-09-19 | 2002-02-19 | Genentech, Inc. | Ligand homologues |
US6030831A (en) * | 1997-09-19 | 2000-02-29 | Genetech, Inc. | Tie ligand homologues |
FR2783325A1 (fr) * | 1998-09-11 | 2000-03-17 | Inst Nat Sante Rech Med | Moyens pour le controle de la regulation negative d'une activation transmise par un rtk |
US6365154B1 (en) * | 1998-09-28 | 2002-04-02 | Smithkline Beecham Corporation | Tie2 agonist antibodies |
US6376653B1 (en) * | 1998-09-28 | 2002-04-23 | Smithkline Beecham Plc | Tie2 antagonist antibodies |
US7488590B2 (en) * | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
US6521424B2 (en) | 1999-06-07 | 2003-02-18 | Immunex Corporation | Recombinant expression of Tek antagonists |
EP1187918B9 (de) * | 1999-06-07 | 2009-08-19 | Immunex Corporation | Tek-antagonisten |
US6346247B1 (en) | 1999-10-28 | 2002-02-12 | Promega Corporation | Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
JP4981229B2 (ja) * | 2000-02-25 | 2012-07-18 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | ハイブリッド血管内皮成長因子DNAsおよびタンパク質に関与する物質および方法 |
WO2001072339A2 (en) * | 2000-03-30 | 2001-10-04 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method of treatment of conditions involving obstruction of blood flow |
ATE480622T1 (de) * | 2000-11-06 | 2010-09-15 | Cancer Rec Tech Ltd | Bildgebende verfahren, diagnose und behandlung von krankheiten |
US7138370B2 (en) | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
US7658924B2 (en) * | 2001-10-11 | 2010-02-09 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US7521053B2 (en) * | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US7205275B2 (en) * | 2001-10-11 | 2007-04-17 | Amgen Inc. | Methods of treatment using specific binding agents of human angiopoietin-2 |
ATE530577T1 (de) * | 2002-05-10 | 2011-11-15 | Purdue Research Foundation | Epha2 agonistische monoklonale antikörper und deren anwendungsverfahren |
ES2373715T3 (es) * | 2002-05-10 | 2012-02-08 | Medimmune, Llc | Anticuerpos monoclonales frente a epha2 y procedimientos de uso de los mismos. |
US20050152899A1 (en) * | 2002-05-10 | 2005-07-14 | Kinch Michael S. | EphA2 agonistic monoclonal antibodies and methods of use thereof |
BRPI0311182A2 (pt) * | 2002-05-16 | 2016-06-21 | Absorber Ab | método para isolar uma célula endotelial e método para realizar provas cruzadas específicas para o doador |
JP4869603B2 (ja) | 2002-11-20 | 2012-02-08 | キャンサー・リサーチ・テクノロジー・リミテッド | 抗体、ポリペプチドおよびその使用 |
US20050049176A1 (en) * | 2003-04-11 | 2005-03-03 | Kiener Peter A. | EphA2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
AU2004229543A1 (en) * | 2003-04-11 | 2004-10-28 | Medimmune, Llc | EphA2 and non-neoplastic hyperproliferative cell disorders |
EP1479760A1 (de) * | 2003-05-19 | 2004-11-24 | ProBioGen AG | Künstliches Immunorgan |
US7871610B2 (en) * | 2003-08-12 | 2011-01-18 | Dyax Corp. | Antibodies to Tie1 ectodomain |
US7485297B2 (en) * | 2003-08-12 | 2009-02-03 | Dyax Corp. | Method of inhibition of vascular development using an antibody |
CA2535171A1 (en) * | 2003-08-12 | 2005-03-03 | Dyax Corp. | Tie1-binding ligands |
US8298532B2 (en) * | 2004-01-16 | 2012-10-30 | Regeneron Pharmaceuticals, Inc. | Fusion polypeptides capable of activating receptors |
ATE504599T1 (de) * | 2004-01-16 | 2011-04-15 | Regeneron Pharma | Zur aktivierung von rezeptoren fähige fusionspolypeptide |
JP2007528222A (ja) * | 2004-03-09 | 2007-10-11 | アブソルバー, アーベー | 内皮前駆細胞およびその使用方法 |
AU2005272848A1 (en) * | 2004-08-12 | 2006-02-23 | Dyax Corp. | Tie complex binding proteins |
US20090170769A1 (en) * | 2005-05-13 | 2009-07-02 | Pei Jin | Cell surface receptor isoforms and methods of identifying and using the same |
US20080213253A1 (en) * | 2007-01-12 | 2008-09-04 | Dyax Corp. | Combination therapy for the treatment of cancer |
JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
US9109446B1 (en) | 2011-02-07 | 2015-08-18 | Ameriband, Llc | Continuously variable displacement engine |
US9540932B1 (en) | 2011-02-07 | 2017-01-10 | Ameriband, Llc | Continuously variable displacement engine |
US10041405B1 (en) | 2011-02-07 | 2018-08-07 | Ameriband, Llc | Continuously variable displacement engine |
US9896933B1 (en) | 2011-02-07 | 2018-02-20 | Ameriband, Llc | Continuously variable displacement engine |
US9581057B1 (en) | 2014-08-20 | 2017-02-28 | Ameriband, Llc | Valve actuator system capable of operating multiple valves with a single cam |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07506242A (ja) * | 1992-01-09 | 1995-07-13 | ヘルシンキ ユニバーシティ ホルディング リミテッド | Tie,新規内皮細胞受容体チロシンキナーゼ |
US5955291A (en) * | 1992-01-09 | 1999-09-21 | Alitalo; Kari | Antibodies recognizing tie receptor tyrosine kinase and uses thereof |
-
1994
- 1994-03-29 US US08/220,240 patent/US5955291A/en not_active Expired - Lifetime
-
1995
- 1995-03-29 EP EP95914366A patent/EP0753015B1/de not_active Expired - Lifetime
- 1995-03-29 WO PCT/FI1995/000170 patent/WO1995026364A1/en active IP Right Grant
- 1995-03-29 DK DK95914366T patent/DK0753015T3/da active
- 1995-03-29 DE DE69518406T patent/DE69518406T2/de not_active Expired - Lifetime
- 1995-03-29 NZ NZ283366A patent/NZ283366A/en not_active IP Right Cessation
- 1995-03-29 CA CA002185043A patent/CA2185043C/en not_active Expired - Fee Related
- 1995-03-29 ES ES95914366T patent/ES2151595T3/es not_active Expired - Lifetime
- 1995-03-29 JP JP52498895A patent/JP3683270B2/ja not_active Expired - Fee Related
- 1995-03-29 AU AU21392/95A patent/AU697185B2/en not_active Ceased
- 1995-03-29 MX MX9604391A patent/MX9604391A/es not_active IP Right Cessation
- 1995-03-29 AT AT95914366T patent/ATE195533T1/de active
-
1996
- 1996-09-24 NO NO19964013A patent/NO319586B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0753015T3 (da) | 2000-11-13 |
JP3683270B2 (ja) | 2005-08-17 |
NO319586B1 (no) | 2005-08-29 |
AU697185B2 (en) | 1998-10-01 |
WO1995026364A1 (en) | 1995-10-05 |
US5955291A (en) | 1999-09-21 |
DE69518406D1 (de) | 2000-09-21 |
EP0753015A1 (de) | 1997-01-15 |
EP0753015B1 (de) | 2000-08-16 |
CA2185043C (en) | 2008-03-18 |
NZ283366A (en) | 1998-04-27 |
NO964013L (no) | 1996-09-24 |
ATE195533T1 (de) | 2000-09-15 |
JPH09511141A (ja) | 1997-11-11 |
AU2139295A (en) | 1995-10-17 |
ES2151595T3 (es) | 2001-01-01 |
MX9604391A (es) | 1997-07-31 |
NO964013D0 (no) | 1996-09-24 |
CA2185043A1 (en) | 1995-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE195533T1 (de) | Monoklonale antikörper gegen den tie-rezeptor und deren verwendung | |
ATE108666T1 (de) | Ultraschall-kontrastmittel, verfahren zu ihrer herstellung und verwendung derselben als diagnostika und therapeutika. | |
ATE110172T1 (de) | Antikörper gegen menschlichen progesteronrezeptor sowie diagnosematerial und -verfahren. | |
ATE388167T1 (de) | Menschlicher antikörper gegen gangliosid gd3 für die transplantationskomplementarität bestimmente regionund derivate des antikörpers gegen das gangliosid gd3 | |
EP0671920A4 (de) | Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten. | |
NL300985I1 (en) | mogamulizumab | |
DK0807125T3 (da) | Monoklonale antistoffer mod CD6 til behandling og diagnosticering af psoriasis | |
ATE368055T1 (de) | Monoklonale antikörper gegen den interferonrezeptor, mit neutralisierender aktivität gegen typ i-interferon | |
DE69334259D1 (de) | Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierungs-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyten beschränkt ist, für die Behandlung von B-Zell-Lymphoma | |
ATE301676T1 (de) | Antikörper gegen die ed-b domäne von fibronektin, solche antikörper enthaltende konjugate, und deren verwendung zur diagnose und therapie von angiogenese-assoziierten tumoren und krankheiten | |
CA2093928A1 (en) | Monoclonal antibodies for detection and treatment of cancer | |
NO20031323L (no) | Peptid-baserte forbindelser | |
ES2138729T3 (es) | Metodos de diagnostico de la preeclampsia. | |
BR0113213A (pt) | Método para diagnosticar uma doença auto-imune, anticorpo, composição de diagnóstico, e, uso do anticorpo | |
DE60129278D1 (de) | Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen | |
DE60128452D1 (de) | Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung | |
DE60029953D1 (de) | Spezifische antikörper gegen humanes choriongonadotropin hormone und deren verwendung in therapie und diagnose | |
AU4098201A (en) | Method for diagnosing efficacy of xenotypic antibody therapy | |
DE59207362D1 (de) | Monoklonale Antikörper gegen den Plasmin-Antiplasmin Komplex, Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
DE59310204D1 (de) | Spezifische Antikörper gegen aktivierte Plättchen, ihre Herstellung und ihre Verwendung in Diagnose und Therapie | |
ES2149155T3 (es) | Peptidos sinteticos que contienen secuencias de factor viia y su utilizacion. | |
李斯德 et al. | STUDY OF RADIOIMMUNOIMAGING WITH MONOCLONAL ANTIBODY AGAINST THE PATIENTS WITH SCLC | |
ATE95426T1 (de) | Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: LICENTIA LTD., HELSINKI, FI |
|
8381 | Inventor (new situation) |
Inventor name: ALITALO, KARI, ESPOO, FI Inventor name: MATIKAINEN, MARJA-TERTTU, MYNÄMÄKI, FI Inventor name: KARNANI, PÄIVI, TURKU, FI |